Moving on obesity treatment in CKD: inertia is unjustified.
作者信息
Zoccali Carmine
机构信息
Renal Research Institute NY, USA.
BIOGEM, Ariano Irpino, Italy.
出版信息
Clin Kidney J. 2023 Nov 22;17(1):sfad275. doi: 10.1093/ckj/sfad275. eCollection 2024 Jan.
Abstract
摘要
相似文献
1
Moving on obesity treatment in CKD: inertia is unjustified.推进慢性肾脏病的肥胖治疗：不作为是不合理的。
Clin Kidney J. 2023 Nov 22;17(1):sfad275. doi: 10.1093/ckj/sfad275. eCollection 2024 Jan.
2
Correction to: Moving on obesity treatment in CKD: inertia is unjustified.对《慢性肾脏病肥胖治疗的进展：惰性是不合理的》一文的勘误
Clin Kidney J. 2024 May 24;17(5):sfae149. doi: 10.1093/ckj/sfae149. eCollection 2024 May.
3
Management of CKD-MBD in non-dialysis patients under regular nephrology care: a prospective multicenter study.常规肾脏病护理下非透析患者慢性肾脏病-矿物质和骨异常的管理：一项前瞻性多中心研究。
J Nephrol. 2016 Feb;29(1):71-8. doi: 10.1007/s40620-015-0202-4. Epub 2015 May 19.
4
Moderator's view: Phosphate binders in chronic kidney disease patients: a clear 'No' at the moment, but stay tuned.主持人观点：目前慢性肾脏病患者应避免使用磷结合剂，但需保持关注。
Nephrol Dial Transplant. 2016 Feb;31(2):196-9. doi: 10.1093/ndt/gfv404. Epub 2015 Dec 17.
5
Adherence to blood pressure and glucose recommendations in chronic kidney disease hospital inpatients: Clinical inertia and patient adherence.慢性肾脏病住院患者对血压和血糖控制建议的依从性：临床惰性与患者依从性。
Diabetes Metab Syndr. 2018 May;12(3):291-300. doi: 10.1016/j.dsx.2017.12.007. Epub 2017 Dec 16.
6
Physician and patient characteristics associated with clinical inertia in blood pressure control.与血压控制中临床惰性相关的医生和患者特征。
J Clin Hypertens (Greenwich). 2013 Nov;15(11):820-4. doi: 10.1111/jch.12179. Epub 2013 Aug 7.
7
To what extent can we achieve mineral bone metabolism treatment targets suggested by the KDIGO guidelines among chronic kidney disease stage 3 - 5 non-dialysis patients?在慢性肾脏病 3 期-5 期非透析患者中，我们在多大程度上可以实现 KDIGO 指南建议的矿物质骨代谢治疗目标？
Clin Nephrol. 2022 Nov;98(5):239-246. doi: 10.5414/CN110733.
8
Persons With Diabetes and General/Family Practitioner Perspectives Related to Therapeutic Inertia in Type 2 Diabetes Mellitus Using Qualitative Focus Groups and the Theoretical Domains Framework: Results From the MOTION Study.使用定性焦点小组和理论领域框架对 2 型糖尿病治疗惰性的糖尿病患者和全科医生的观点：来自 MOTION 研究的结果。
Can J Diabetes. 2022 Mar;46(2):171-180. doi: 10.1016/j.jcjd.2021.08.004. Epub 2021 Aug 19.
9
The chronic kidney disease epidemic: stepping back and looking forward.慢性肾病的流行：回顾与展望
J Am Soc Nephrol. 2006 Nov;17(11):2967-73. doi: 10.1681/ASN.2006020123. Epub 2006 Oct 11.
10
Unjustified Administration in Liberal Use of Tranexamic Acid in Trauma Resuscitation.创伤复苏中氨甲环酸的过度使用是不合理的。
J Surg Res. 2021 Feb;258:125-131. doi: 10.1016/j.jss.2020.08.045. Epub 2020 Sep 30.
本文引用的文献
1
Ketogenic metabolic therapy for chronic kidney disease - the pro part.用于慢性肾脏病的生酮代谢疗法——支持方观点。
Clin Kidney J. 2023 Nov 7;17(1):sfad273. doi: 10.1093/ckj/sfad273. eCollection 2024 Jan.
2
Risks of the ketogenic diet in CKD - the con part.慢性肾脏病中酮饮食的风险——反对观点。
Clin Kidney J. 2023 Nov 7;17(1):sfad274. doi: 10.1093/ckj/sfad274. eCollection 2024 Jan.
3
Low carbohydrate intake correlates with trends of insulin resistance and metabolic acidosis in healthy lean individuals.低碳水化合物的摄入量与健康瘦个体的胰岛素抵抗和代谢性酸中毒的趋势相关。
Front Public Health. 2023 Mar 16;11:1115333. doi: 10.3389/fpubh.2023.1115333. eCollection 2023.
4
Prevalence of Obesity and CKD Among Adults in the United States, 2017-2020.2017 - 2020年美国成年人肥胖症和慢性肾脏病的患病率
Kidney Med. 2022 Nov 5;5(1):100568. doi: 10.1016/j.xkme.2022.100568. eCollection 2023 Jan.
5
Risks and Benefits of Different Dietary Patterns in CKD.慢性肾脏病中不同饮食模式的风险与益处
Am J Kidney Dis. 2023 Mar;81(3):352-360. doi: 10.1053/j.ajkd.2022.08.013. Epub 2023 Jan 20.
6
The Metabolic Role of Ketogenic Diets in Treating Epilepsy.生酮饮食治疗癫痫的代谢作用。
Nutrients. 2022 Nov 29;14(23):5074. doi: 10.3390/nu14235074.
7
Can ketogenic dietary interventions slow disease progression in ADPKD: what we know and what we don't.生酮饮食干预能否减缓常染色体显性多囊肾病的疾病进展：我们已知和未知的情况。
Clin Kidney J. 2022 Apr 21;15(6):1034-1036. doi: 10.1093/ckj/sfac103. eCollection 2022 Jun.
8
Ketogenic Diets and Chronic Disease: Weighing the Benefits Against the Risks.生酮饮食与慢性病：权衡利弊
Front Nutr. 2021 Jul 16;8:702802. doi: 10.3389/fnut.2021.702802. eCollection 2021.
9
KDOQI Clinical Practice Guideline for Nutrition in CKD: 2020 Update.KDIGO 临床实践指南：慢性肾脏病中的营养治疗 2020 年更新版。
Am J Kidney Dis. 2020 Sep;76(3 Suppl 1):S1-S107. doi: 10.1053/j.ajkd.2020.05.006.
10
Effect of low-carbohydrate diets on cardiometabolic risk, insulin resistance, and metabolic syndrome.低碳水化合物饮食对心脏代谢风险、胰岛素抵抗和代谢综合征的影响。
Curr Opin Endocrinol Diabetes Obes. 2020 Oct;27(5):301-307. doi: 10.1097/MED.0000000000000569.
Zotero 插件